Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies
Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 w...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2014-06, Vol.289 (24), p.17228-17239 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 17239 |
---|---|
container_issue | 24 |
container_start_page | 17228 |
container_title | The Journal of biological chemistry |
container_volume | 289 |
creator | Sand, Kine Marita Knudsen Dalhus, Bjørn Christianson, Gregory J. Bern, Malin Foss, Stian Cameron, Jason Sleep, Darrell Bjørås, Magnar Roopenian, Derry C. Sandlie, Inger Andersen, Jan Terje |
description | Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.
Background: Albumin has a long serum half-life, which is regulated by FcRn.
Results: A cluster of conserved tryptophan residues of FcRn is required for binding to albumin and anti-FcRn albumin blocking antibodies.
Conclusion: The FcRn-albumin interaction is pH-dependent but hydrophobic in nature.
Significance: This study provides mechanistic insight into how FcRn binds albumin and regulates its long half-life. |
doi_str_mv | 10.1074/jbc.M113.522565 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_crist</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4059163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820406921</els_id><sourcerecordid>24764301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-13a5a0846cdfe9d2dd53a8da7a2867874aede55220ee56b7c3ade0912a9904883</originalsourceid><addsrcrecordid>eNp1kc9rFDEUx4Modq2evWmO9jDbJJPMj4uw1K4WWoViwVt4k7zZps4mS5ItiP-8GbYtejCXd3if9yV8P4S85WzJWStP7wazvOK8XiohVKOekQVnXV3Viv94ThaMCV71QnVH5FVKd6w82fOX5EjItpE14wvy-5NLCU12wdMw0nyL9CsGDxkmujb0Gg3ucoj0w9pc-5NqNQ37rfP0wmeMIxikN8n5Db3aZ9igx-QSBW_pymdXzSf04aIapmB-zui8GoJ1mF6TFyNMCd88zGNysz7_fvaluvz2-eJsdVkZ2bS54jUoYJ1sjB2xt8JaVUNnoQXRNW3XSkCLqhTAEFUztKYGi6znAvqeya6rj8nHQ-5uP2zRGvQ5wqR30W0h_tIBnP53492t3oR7LZnqeVOXgPeHABNdys5rHyLo0rQSWknF2kKcPhIhpYjjUzpnejaliyk9m9IHU-Xi3d-feuIf1RSgPwBYqrl3GHUyDr1B62IRpm1w_w3_A-4wo0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies</title><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Sand, Kine Marita Knudsen ; Dalhus, Bjørn ; Christianson, Gregory J. ; Bern, Malin ; Foss, Stian ; Cameron, Jason ; Sleep, Darrell ; Bjørås, Magnar ; Roopenian, Derry C. ; Sandlie, Inger ; Andersen, Jan Terje</creator><creatorcontrib>Sand, Kine Marita Knudsen ; Dalhus, Bjørn ; Christianson, Gregory J. ; Bern, Malin ; Foss, Stian ; Cameron, Jason ; Sleep, Darrell ; Bjørås, Magnar ; Roopenian, Derry C. ; Sandlie, Inger ; Andersen, Jan Terje</creatorcontrib><description>Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.
Background: Albumin has a long serum half-life, which is regulated by FcRn.
Results: A cluster of conserved tryptophan residues of FcRn is required for binding to albumin and anti-FcRn albumin blocking antibodies.
Conclusion: The FcRn-albumin interaction is pH-dependent but hydrophobic in nature.
Significance: This study provides mechanistic insight into how FcRn binds albumin and regulates its long half-life.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M113.522565</identifier><identifier>PMID: 24764301</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Albumin ; Albumins - metabolism ; Amino Acid Sequence ; Antibodies, Blocking - immunology ; Antibodies, Monoclonal - immunology ; Antibody ; Binding Sites ; Biodegradation ; Bioengineering ; Fc Receptor ; FcRn ; Half-life ; Histocompatibility Antigens Class I - chemistry ; Histocompatibility Antigens Class I - genetics ; Histocompatibility Antigens Class I - immunology ; Histocompatibility Antigens Class I - metabolism ; Humans ; Hydrogen-Ion Concentration ; Hydrophobic ; Hydrophobic and Hydrophilic Interactions ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; pH Regulation ; Protein Binding ; Protein Structure and Folding ; Receptors, Fc - chemistry ; Receptors, Fc - genetics ; Receptors, Fc - immunology ; Receptors, Fc - metabolism</subject><ispartof>The Journal of biological chemistry, 2014-06, Vol.289 (24), p.17228-17239</ispartof><rights>2014 © 2014 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2014 by The American Society for Biochemistry and Molecular Biology, Inc.</rights><rights>info:eu-repo/semantics/openAccess</rights><rights>2014 by The American Society for Biochemistry and Molecular Biology, Inc. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-13a5a0846cdfe9d2dd53a8da7a2867874aede55220ee56b7c3ade0912a9904883</citedby><cites>FETCH-LOGICAL-c467t-13a5a0846cdfe9d2dd53a8da7a2867874aede55220ee56b7c3ade0912a9904883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059163/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059163/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,26544,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24764301$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sand, Kine Marita Knudsen</creatorcontrib><creatorcontrib>Dalhus, Bjørn</creatorcontrib><creatorcontrib>Christianson, Gregory J.</creatorcontrib><creatorcontrib>Bern, Malin</creatorcontrib><creatorcontrib>Foss, Stian</creatorcontrib><creatorcontrib>Cameron, Jason</creatorcontrib><creatorcontrib>Sleep, Darrell</creatorcontrib><creatorcontrib>Bjørås, Magnar</creatorcontrib><creatorcontrib>Roopenian, Derry C.</creatorcontrib><creatorcontrib>Sandlie, Inger</creatorcontrib><creatorcontrib>Andersen, Jan Terje</creatorcontrib><title>Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.
Background: Albumin has a long serum half-life, which is regulated by FcRn.
Results: A cluster of conserved tryptophan residues of FcRn is required for binding to albumin and anti-FcRn albumin blocking antibodies.
Conclusion: The FcRn-albumin interaction is pH-dependent but hydrophobic in nature.
Significance: This study provides mechanistic insight into how FcRn binds albumin and regulates its long half-life.</description><subject>Albumin</subject><subject>Albumins - metabolism</subject><subject>Amino Acid Sequence</subject><subject>Antibodies, Blocking - immunology</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibody</subject><subject>Binding Sites</subject><subject>Biodegradation</subject><subject>Bioengineering</subject><subject>Fc Receptor</subject><subject>FcRn</subject><subject>Half-life</subject><subject>Histocompatibility Antigens Class I - chemistry</subject><subject>Histocompatibility Antigens Class I - genetics</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hydrophobic</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>pH Regulation</subject><subject>Protein Binding</subject><subject>Protein Structure and Folding</subject><subject>Receptors, Fc - chemistry</subject><subject>Receptors, Fc - genetics</subject><subject>Receptors, Fc - immunology</subject><subject>Receptors, Fc - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>3HK</sourceid><recordid>eNp1kc9rFDEUx4Modq2evWmO9jDbJJPMj4uw1K4WWoViwVt4k7zZps4mS5ItiP-8GbYtejCXd3if9yV8P4S85WzJWStP7wazvOK8XiohVKOekQVnXV3Viv94ThaMCV71QnVH5FVKd6w82fOX5EjItpE14wvy-5NLCU12wdMw0nyL9CsGDxkmujb0Gg3ucoj0w9pc-5NqNQ37rfP0wmeMIxikN8n5Db3aZ9igx-QSBW_pymdXzSf04aIapmB-zui8GoJ1mF6TFyNMCd88zGNysz7_fvaluvz2-eJsdVkZ2bS54jUoYJ1sjB2xt8JaVUNnoQXRNW3XSkCLqhTAEFUztKYGi6znAvqeya6rj8nHQ-5uP2zRGvQ5wqR30W0h_tIBnP53492t3oR7LZnqeVOXgPeHABNdys5rHyLo0rQSWknF2kKcPhIhpYjjUzpnejaliyk9m9IHU-Xi3d-feuIf1RSgPwBYqrl3GHUyDr1B62IRpm1w_w3_A-4wo0A</recordid><startdate>20140613</startdate><enddate>20140613</enddate><creator>Sand, Kine Marita Knudsen</creator><creator>Dalhus, Bjørn</creator><creator>Christianson, Gregory J.</creator><creator>Bern, Malin</creator><creator>Foss, Stian</creator><creator>Cameron, Jason</creator><creator>Sleep, Darrell</creator><creator>Bjørås, Magnar</creator><creator>Roopenian, Derry C.</creator><creator>Sandlie, Inger</creator><creator>Andersen, Jan Terje</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3HK</scope><scope>5PM</scope></search><sort><creationdate>20140613</creationdate><title>Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies</title><author>Sand, Kine Marita Knudsen ; Dalhus, Bjørn ; Christianson, Gregory J. ; Bern, Malin ; Foss, Stian ; Cameron, Jason ; Sleep, Darrell ; Bjørås, Magnar ; Roopenian, Derry C. ; Sandlie, Inger ; Andersen, Jan Terje</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-13a5a0846cdfe9d2dd53a8da7a2867874aede55220ee56b7c3ade0912a9904883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Albumin</topic><topic>Albumins - metabolism</topic><topic>Amino Acid Sequence</topic><topic>Antibodies, Blocking - immunology</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibody</topic><topic>Binding Sites</topic><topic>Biodegradation</topic><topic>Bioengineering</topic><topic>Fc Receptor</topic><topic>FcRn</topic><topic>Half-life</topic><topic>Histocompatibility Antigens Class I - chemistry</topic><topic>Histocompatibility Antigens Class I - genetics</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hydrophobic</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>pH Regulation</topic><topic>Protein Binding</topic><topic>Protein Structure and Folding</topic><topic>Receptors, Fc - chemistry</topic><topic>Receptors, Fc - genetics</topic><topic>Receptors, Fc - immunology</topic><topic>Receptors, Fc - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sand, Kine Marita Knudsen</creatorcontrib><creatorcontrib>Dalhus, Bjørn</creatorcontrib><creatorcontrib>Christianson, Gregory J.</creatorcontrib><creatorcontrib>Bern, Malin</creatorcontrib><creatorcontrib>Foss, Stian</creatorcontrib><creatorcontrib>Cameron, Jason</creatorcontrib><creatorcontrib>Sleep, Darrell</creatorcontrib><creatorcontrib>Bjørås, Magnar</creatorcontrib><creatorcontrib>Roopenian, Derry C.</creatorcontrib><creatorcontrib>Sandlie, Inger</creatorcontrib><creatorcontrib>Andersen, Jan Terje</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sand, Kine Marita Knudsen</au><au>Dalhus, Bjørn</au><au>Christianson, Gregory J.</au><au>Bern, Malin</au><au>Foss, Stian</au><au>Cameron, Jason</au><au>Sleep, Darrell</au><au>Bjørås, Magnar</au><au>Roopenian, Derry C.</au><au>Sandlie, Inger</au><au>Andersen, Jan Terje</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2014-06-13</date><risdate>2014</risdate><volume>289</volume><issue>24</issue><spage>17228</spage><epage>17239</epage><pages>17228-17239</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Albumin is the most abundant protein in blood and plays a pivotal role as a multitransporter of a wide range of molecules such as fatty acids, metabolites, hormones, and toxins. In addition, it binds a variety of drugs. Its role as distributor is supported by its extraordinary serum half-life of 3 weeks. This is related to its size and binding to the cellular receptor FcRn, which rescues albumin from intracellular degradation. Furthermore, the long half-life has fostered a great and increasing interest in utilization of albumin as a carrier of protein therapeutics and chemical drugs. However, to fully understand how FcRn acts as a regulator of albumin homeostasis and to take advantage of the FcRn-albumin interaction in drug design, the interaction interface needs to be dissected. Here, we used a panel of monoclonal antibodies directed towards human FcRn in combination with site-directed mutagenesis and structural modeling to unmask the binding sites for albumin blocking antibodies and albumin on the receptor, which revealed that the interaction is not only strictly pH-dependent, but predominantly hydrophobic in nature. Specifically, we provide mechanistic evidence for a crucial role of a cluster of conserved tryptophan residues that expose a pH-sensitive loop of FcRn, and identify structural differences in proximity to these hot spot residues that explain divergent cross-species binding properties of FcRn. Our findings expand our knowledge of how FcRn is controlling albumin homeostasis at a molecular level, which will guide design and engineering of novel albumin variants with altered transport properties.
Background: Albumin has a long serum half-life, which is regulated by FcRn.
Results: A cluster of conserved tryptophan residues of FcRn is required for binding to albumin and anti-FcRn albumin blocking antibodies.
Conclusion: The FcRn-albumin interaction is pH-dependent but hydrophobic in nature.
Significance: This study provides mechanistic insight into how FcRn binds albumin and regulates its long half-life.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24764301</pmid><doi>10.1074/jbc.M113.522565</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2014-06, Vol.289 (24), p.17228-17239 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4059163 |
source | MEDLINE; NORA - Norwegian Open Research Archives; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library |
subjects | Albumin Albumins - metabolism Amino Acid Sequence Antibodies, Blocking - immunology Antibodies, Monoclonal - immunology Antibody Binding Sites Biodegradation Bioengineering Fc Receptor FcRn Half-life Histocompatibility Antigens Class I - chemistry Histocompatibility Antigens Class I - genetics Histocompatibility Antigens Class I - immunology Histocompatibility Antigens Class I - metabolism Humans Hydrogen-Ion Concentration Hydrophobic Hydrophobic and Hydrophilic Interactions Molecular Sequence Data Mutagenesis, Site-Directed pH Regulation Protein Binding Protein Structure and Folding Receptors, Fc - chemistry Receptors, Fc - genetics Receptors, Fc - immunology Receptors, Fc - metabolism |
title | Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_crist&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dissection%20of%20the%20Neonatal%20Fc%20Receptor%20(FcRn)-Albumin%20Interface%20Using%20Mutagenesis%20and%20Anti-FcRn%20Albumin-blocking%20Antibodies&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Sand,%20Kine%20Marita%20Knudsen&rft.date=2014-06-13&rft.volume=289&rft.issue=24&rft.spage=17228&rft.epage=17239&rft.pages=17228-17239&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M113.522565&rft_dat=%3Cpubmed_crist%3E24764301%3C/pubmed_crist%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24764301&rft_els_id=S0021925820406921&rfr_iscdi=true |